On September 14, 2023, the Federal Trade Commission (FTC) issued a statement condemning pharmaceutical manufacturers’ improper inclusion of patents in the Food and Drug Administration’s (FDA’s) ...

The USPTO today released two memos meant to provide additional guidance around the use of patent subject matter eligibility declarations for examiners, applicants and practitioners.

China’s courts are increasingly willing to hear actions for declarations of non-infringement of patents. Qi Wang and Shaohui Du of Deqi explain how to make the most of the procedure As judicial ...

LexisNexis ® Intellectual Property Solutions Achieves 99.9% Data Accuracy for 5G Patents Through Collaboration With Top ETSI-Declaring Companies to Match, Clean, Expand, and Verify Patent Declaration ...

Even with U.N.’s previous goals unmet, delegates tried to water down provisions regarding protections for vulnerable populations and patents for essential drugs. By Apoorva Mandavilli The United ...

The rules for licensing the patents essential for standards are hard to understand, even for experts. Participants in standards bodies, whether or not ANSI-accredited, have claimed that their duty to ...

Generic companies can seek court declarations that their own products are old or obvious in patent law terms under certain circumstances, the England & Wales Court of Appeal has ruled The Court's ...

The latest edition of this annual report builds again on one of the world's most comprehensive and up-to-date data sets of patent declarations from LexisNexis ® IPlytics™. As experts only classify ...